![Page 1: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/1.jpg)
TUMOUR IMMUNOLOGY
Sukchai Satthaporn MD. PhD.Department of Surgery
Pramongkutklao Hospital and College of Medicine
![Page 2: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/2.jpg)
Contents
• Immunosurveillance• Effector mechanisms in anti-tumour
immunity• Mechanisms of tumour evasion of the
immune system• Immunotherapy for tumours
![Page 3: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/3.jpg)
Immunosurveillance
• An hypothesis states physiologic function of the immune system is to recognize and destroy malignantly transformed cells before they grow into tumours
• Implies that cells of the immune system recognize something “foreign” on transformed/tumour cells
Proposed by Paul Ehrlich, Macfarlane Burnet and Lewis Thomas
![Page 4: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/4.jpg)
Immunosurveillance
• The immune system has evolved in all species mainly to fight and prevent foreign invasions from infectious pathogens
• Immune system can also respond against internal attacks such as those resulting from malignant transformation
![Page 5: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/5.jpg)
Evidence in Support of Immunosurveillance (I)
• Immunodeficient individuals are more likely to develop certain types of tumoursthan immunocompetent individuals- Congenital immune deficiency- AIDS associated tumours- Transplantation recipients
![Page 6: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/6.jpg)
Evidence in Support of Immunosurveillance (II)
• Clinicopathologic correlations suggest that lymphocytic infiltrates in some tumours(e.g. medullary breast carcinoma, malignant melanoma) are associated with a better prognosis compared to histologically similar tumours without infiltrates
![Page 7: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/7.jpg)
![Page 8: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/8.jpg)
Tumour Infiltrating Lymphocytes(TILs) and Macrophages (TIMs)
![Page 9: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/9.jpg)
Evidence in Support of Immunosurveillance (II)
• Histologic evidence indicates that active immune responses occur within tumoursor in draining lymph nodes
![Page 10: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/10.jpg)
Tumour Draining Lymph Node
![Page 11: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/11.jpg)
Evidence in Support of Immunosurveillance (III)
• There is evidence that T and B lymphocytes specific for tumour surface molecules have been activated and expanded in tumour patients but hyporeactivity
![Page 12: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/12.jpg)
Tumour Draining LN Lymphocyte Hyporeactivity
![Page 13: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/13.jpg)
Spontaneous Regression of Cancer
• Number of cases: (Index Medicus and Cancer Lit: 1966-1987)• Leukemia/Lymphoma 124• Melanoma 69• Renal cell cancer 68• Neuroblastoma 41• Gastrointestinal cancer 34• Retinoblastoma 33• otal: 504• Lung and Bronchus 25• Breast 22• Testis 16• Head and neck (sq. cell) 8• Other 64
![Page 14: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/14.jpg)
Immunosurveillance
• Classic experiments by Gross in the 1940’s demonstrating that mice that rejected a syngeneic murine sarcoma, developed protective immunity to subsequent injections of the same tumour
• Gross L. Cancer Research 3:326,1943; Prehn R. JNCI 18:769, 1957
![Page 15: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/15.jpg)
Figure 14-10
![Page 16: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/16.jpg)
Mechanisms of Tumour Killing
![Page 17: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/17.jpg)
Eremin O and Sewell H. The Immunological Basis of Surgical Science and Practice. 1992.
![Page 18: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/18.jpg)
Mechanisms in tumour Immunity
HumoralOpsonization and phagocytosis
Complement-mediated lysis
Loss of cell adhesion (antibody
dependent)
Cell-Mediated CytotoxicityT Cell (CTLs)
Antibody-dependent cytotoxicity
NK
LAK (lymphokine-activated killer) cells
Macrophages (macrophages can be activated by lymphokines)
![Page 19: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/19.jpg)
Figure 14-13
![Page 20: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/20.jpg)
Antibodies
• activity demonstrated mainly in vitro• most tumour-specific antigens do not elicit antibody responses in vivo
![Page 21: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/21.jpg)
Activated macrophages
• activity demonstrated mainly in vitro• Tumour cells may be more susceptible to
macrophage-mediated killing than normal cells
![Page 22: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/22.jpg)
NK cells
• Recognize lack of normal self class I MHC on some tumors
• Kill tumor cells in vitro by aperforin/granzyme granule exocytosismechanisms similar to CTLs
• May be defense against tumors which have escaped CTL killing
![Page 23: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/23.jpg)
![Page 24: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/24.jpg)
![Page 25: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/25.jpg)
Figure 8-22 part 1 of 2
![Page 26: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/26.jpg)
A B
![Page 27: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/27.jpg)
Figure 8-31
![Page 28: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/28.jpg)
Mechanisms of Tumour Evasion of the Immune System
![Page 29: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/29.jpg)
Tumour Evades Host Immune System
• Tumours can evade the immune response by manipulating these pathways-TRICKY!!
• We need to manipulate the host immune system to overcome the tumour’s tricks
• Rammensee H. Immunogenetics 50:213, 1999; Greenberg PD. Advances in Immunology 49:281, 1991
![Page 30: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/30.jpg)
Figure 14-14
![Page 31: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/31.jpg)
Immunotherapy
• Active immunotherapy–Specific–Non-specific
• Passive immunotherapy–Specific–Non-specific
![Page 32: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/32.jpg)
Active Specific Immunotherapy
![Page 33: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/33.jpg)
Active Non-specific Immunotherapy
• Stimulated by the local administration of inflammatory substances or by systemic treatment with agents that function as polyclonal activators
• Activate macrophages or stimulate T cell responses
• Bacillus Calmette-Guerin (BCG) : carcinoma of the bladder
![Page 34: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/34.jpg)
Passive Specific Immunotherapy
![Page 35: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/35.jpg)
Passive Non-specific Immunotherapy
• Adoptive cellular immunotherapy– Isolate lymphocytes from blood or tumour
infiltrate– Expand lymphocytes by culture in IL-2
lymphokine-activated killer (LAK) cells – Transfer LAK cells into patient, with or
without systemic IL-2
![Page 36: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/36.jpg)
Passive Non-specific Immunotherapy
• Cytokine Immunotherapy– Tumor necrosis factor (TNF): Rx of sarcomas– Type I interferons (IFN-a/b): Approved for
chronic myleoid and hairy cellleukemias, AIDS-related Kaposi’s sarcoma
– Interleukin-2: Rx for reanl cell carcinoma and melanoma
![Page 37: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/37.jpg)
Anti-Tumour Vaccines
• Goal: To boost weak cell-mediated immune responses to tumor antigens
• Both helper T cell and CTL responses
![Page 38: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/38.jpg)
Anti-Tumour Vaccines
• Form of vaccine– Peptides– Dendritic cells pulsed with tumor peptides– Cells expressing recombinant genes
encoding tumor antigens– DNA encoding tumor antigens
![Page 39: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/39.jpg)
![Page 40: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/40.jpg)
![Page 41: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/41.jpg)
![Page 42: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/42.jpg)
![Page 43: TUMOUR IMMUNOLOGYrcst.or.th/userfiles/Tumor Immun.pdf · TUMOUR IMMUNOLOGY Sukchai Satthaporn MD. PhD. Department of Surgery Pramongkutklao Hospital and College of Medicine. Contents](https://reader034.vdocuments.net/reader034/viewer/2022042803/5f448fa25572294e8e70ee20/html5/thumbnails/43.jpg)
Thank you for your attention